Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human Pilot Study of 99mTc-RWY for Breast Cancer Imaging
NCT04289532Phase 1Completed
- Sponsor
- Peking University
- Start
- Mar 2018
- Primary completion
- Jun 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 99mtc-rwy in breast cancer, sponsored by Peking University. Primary endpoints: Blood Clearance at 120 months, Excretion and 2 more. Started Mar 2018; status: completed.
02
Drugs
99mtc-rwy
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04289532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04289532.